The Latest From CureMatch
A featured article in The Scientist magazine highlights CureMatch co-founder Dr. Razelle Kurzrock and her clinical use of personalized drug combinations therapies at the Center for Personalized Cancer Therapy at the University of California, San Diego. The advances in personalized cancer treatments appear to lead to better results for cancer patients. Check out the entire […]
CureMatch is honored to be selected to present at the 2018 Biocom Life Science Partnering Conference. The Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. CureMatch has developed a proprietary software platform aimed at guiding oncologists […]
Laguna Niguel, CA – December 13, 2017: Igor F. Tsigelny, Ph.D. and Eden Romm of CureMatch will be presenting at AIMed, the most comprehensive conference on Artificial Intelligence (AI) in medicine, on Wednesday, December 13. Romm and Tsigelny along with Valentina L. Kouznetsova authored “Machine-Learning Models for Selection of Drug-Candidates for Treatment of Alzheimer’s Disease”, one […]
4D Approach to Examining Structural and Functional Changes of Proteins Published in International Computational Intelligence Book SAN DIEGO, CA – December 7, 2017: CureMatch Co-Founders Igor F. Tsigelny, Ph.D. and Razelle Kurzrock, M.D. along with colleagues from UC San Diego and University of Bergen have authored a personalized cancer medicine study examining activation of protein complexes […]
LISBON, PORTUGAL – CureMatch is proud to announce that CureMatch Chief Technology Officer and co-founder, Igor Tsigelny, PhD was invited in November as a plenary speaker to the PCS 4th Annual Global Cancer Conference-2017 in Lisbon, Portugal. The international meeting focused on basic research and clinical cancer research. Presentations and discussions concerning top cancer killers […]